SCHEMBL7145353

SCHEMBL7145353

CN(CCOC1CCCCO1)c1cc(NC(=O)OC(C)(C)C)c([N+](=O)[O-])cc1I

nearest known ligand 0.33

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HCAR3 P49019 1/20 0.33
MAPT P10636 5/20 0.33
ALDH1A1 P00352 5/20 0.33
L3MBTL1 Q9Y468 2/20 0.33
KMT2A Q03164 5/20 0.32
MEN1 O00255 3/20 0.32
CREBBP Q92793 1/20 0.31
NPC1 O15118 1/20 0.31
RAB9A P51151 1/20 0.31
SMN1; SMN2 Q16637 1/20 0.31
HPGD P15428 1/20 0.30
MMP1 P03956 1/20 0.30
MMP2 P08253 1/20 0.30
MMP9 P14780 1/20 0.30
MMP8 P22894 1/20 0.30
MMP13 P45452 1/20 0.30
THRB P10828 1/20 0.30
CYP1A2 P05177 1/20 0.30
CYP2C9 P11712 1/20 0.30
CYP2C19 P33261 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7143475 0.84 KMT2A (0.35) HCAR3MAPTALDH1A1L3MBTL1KMT2A
SCHEMBL7148407 0.83 ADRA2A (0.33) HCAR3MAPTALDH1A1L3MBTL1KMT2A
SCHEMBL7140551 0.83 HCAR3 (0.36) HCAR3MAPTALDH1A1L3MBTL1KMT2A
SCHEMBL7145386 0.81 ALDH1A1 (0.47) HCAR3MAPTALDH1A1KMT2AMEN1
SCHEMBL7147347 0.80 MAPT (0.36) HCAR3MAPTALDH1A1L3MBTL1KMT2A
SCHEMBL6165036 0.77 MAPT (0.40) HCAR3MAPTALDH1A1KMT2AMEN1
SCHEMBL5563454 0.77 KMT2A (0.38) HCAR3MAPTALDH1A1L3MBTL1KMT2A
SCHEMBL7143075 0.76 MAPT (0.35) HCAR3MAPTALDH1A1L3MBTL1KMT2A
SCHEMBL7143905 0.74 MAPT (0.34) HCAR3MAPTALDH1A1L3MBTL1KMT2A
SCHEMBL7143903 0.74 MAPT (0.34) HCAR3MAPTALDH1A1L3MBTL1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1224174-B1 BENZODIAZEPINE DERIVATIVES AS METABOTROPIC GLUTAMATE RECEPTOR ANTAGONISTS HOFFMANN LA ROCHE (CH) 2003-09-17 EP disclosed
EP-1224174-A2 BENZODIAZEPINE DERIVATIVES AS METABOTROPIC GLUTAMATE RECEPTOR ANTAGONISTS F. HOFFMANN-LA ROCHE AG (CH) 2002-07-24 EP disclosed
US-6407094-B1 4-5-DIDEHYDRO-1,5-BENZODIAZEPIN-2-ONE DERIVATIVES; PSYCHOLOGICAL, NERVOUS SYSTEM, AND BRAIN DISORDERS; COGNITION ACTIVATORS; ALZHEIMER*S DISEASE, SCHIZOPHRENIA HOFFMANN-LA ROCHE INC. 2002-06-18 US disclosed
WO-2001029011-A2 BENZODIAZEPINE DERIVATIVES AS METABOTROPIC GLUTAMATE RECEPTOR ANTAGONISTS F. HOFFMANN-LA ROCHE AG (CH) 2001-04-26 WO disclosed